Literature DB >> 11034418

Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist.

H U Simon1, M Weber, E Becker, Y Zilberman, K Blaser, F Levi-Schaffer.   

Abstract

Eosinophils contain in their granules eosinophil cationic protein (ECP) and other basic proteins that have been implicated in immunity to parasites and pathophysiology of chronic allergic responses. In a model of eosinophil degranulation, we show that eosinophils release ECP upon short-term GM-CSF priming and stimulation with either platelet-activating factor (PAF) or the anaphylatoxin C5a, but not eotaxin. Restimulation with the same agonist (PAF or C5a) was unsuccessful as assessed by monitoring intracellular calcium concentration and ECP release. In contrast, upon an intermediate washing step, eosinophils rapidly transduced PAF and C5a signals followed by significant ECP releases. Ligand-binding studies demonstrated that only a proportion of PAF receptors is internalized upon cell stimulation and that washing of the cells removes the agonist from the cell surface. Upon repetitive stimulation, eosinophils with less than 50% of the original ECP content were obtained. Such eosinophils did not increase cellular ECP levels even in the presence of the eosinophil survival factor GM-CSF in overnight cultures. In vivo studies revealed that eosinophils always express detectable amounts of ECP under chronic inflammatory conditions. In conclusion, we have shown that eosinophils maintain their capacity to degranulate upon repetitive stimulation with the same agonist as long as the receptor is not occupied from a previous stimulation. The cellular content of ECP appears to be a no limiting factor in the case of repetitive stimulation, implying that mature eosinophils may not require a significant ECP resynthesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11034418     DOI: 10.4049/jimmunol.165.7.4069

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Generation of eosinophils from unselected bone marrow progenitors: wild-type, TLR- and eosinophil-deficient mice.

Authors:  Kimberly D Dyer; Caroline M Percopo; Helene F Rosenberg
Journal:  Open Immunol J       Date:  2009-01-01

2.  A parallel signal-transduction pathway for eotaxin- and interleukin-5-induced eosinophil shape change.

Authors:  Eun Nam Choi; Moon Kyung Choi; Choon-Sik Park; Il Yup Chung
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

3.  ATG5 promotes eosinopoiesis but inhibits eosinophil effector functions.

Authors:  Nina Germic; Aref Hosseini; Darko Stojkov; Kevin Oberson; Meike Claus; Charaf Benarafa; Sara Calzavarini; Anne Angelillo-Scherrer; Isabelle C Arnold; Anne Müller; Carsten Riether; Shida Yousefi; Hans-Uwe Simon
Journal:  Blood       Date:  2021-05-27       Impact factor: 22.113

4.  Analysis of the Ribonuclease A Superfamily of Antimicrobial Peptides in Patients Undergoing Chronic Peritoneal Dialysis.

Authors:  Neha Dhingra Pottanat; Amy C Brook; Maria Bartosova; Hanna Cortado; Sudipti Gupta; Birong Li; Ashley R Jackson; Martin Vonau; Shira Cohen; Maria Ferrara; Christina B Ching; John David Spencer; Annelie Brauner; Donald J Fraser; Claus Peter Schmitt; Matthias Eberl; Rose Ayoob; Brian Becknell
Journal:  Sci Rep       Date:  2019-05-23       Impact factor: 4.379

5.  The Release Kinetics of Eosinophil Peroxidase and Mitochondrial DNA Is Different in Association with Eosinophil Extracellular Trap Formation.

Authors:  Nina Germic; Timothée Fettrelet; Darko Stojkov; Aref Hosseini; Michael P Horn; Alexander Karaulov; Dagmar Simon; Shida Yousefi; Hans-Uwe Simon
Journal:  Cells       Date:  2021-02-03       Impact factor: 6.600

Review 6.  The Cellular Functions of Eosinophils: Collegium Internationale Allergologicum (CIA) Update 2020.

Authors:  Hans-Uwe Simon; Shida Yousefi; Nina Germic; Isabelle C Arnold; Angela Haczku; Alexander V Karaulov; Dagmar Simon; Helene F Rosenberg
Journal:  Int Arch Allergy Immunol       Date:  2019-11-29       Impact factor: 2.749

7.  Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils.

Authors:  Frank Altznauer; Sibylla Martinelli; Shida Yousefi; Christine Thürig; Inès Schmid; Edward M Conway; Martin H Schöni; Peter Vogt; Christoph Mueller; Martin F Fey; Uwe Zangemeister-Wittke; Hans-Uwe Simon
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.